Kareo vs Drchrono: Which One in 2026?

Five criteria decide Kareo versus Drchrono for an independent medical practice, and price is not one of them because neither vendor publishes a figure we can print. The criteria are: which system is the record for claims, which is the record for the chart, whether you need a certified EHR your clinicians will actually document in, how patient intake and reminders attach to the visit, and what a migration of claims history plus charts would do to the next 90 days of cash.

Name those five before a demo. Practices that skip to "which EHR is nicer" discover in month two that denials still sit in a separate billing tool, or that clinicians still chart in a tablet workflow the new system does not match. Practices that skip to "which billing engine posts faster" discover that notes, e-prescribing, and labs were the actual bottleneck.

Kareo is the name most independent practices still search. The product now sits inside a broader independent-practice platform after a 2021 combination with a practice-growth company. This page still treats Kareo as the billing-and-practice-management side of that lineage, because that is the job buyers mean when they type the comparison. Drchrono is the clinical EHR with scheduling, charting, e-prescribing, labs, and billing on a web and mobile stack.

TL;DR: Choose Kareo when the practice's live pain is claims, eligibility, and getting paid as an independent shop; choose Drchrono when the live pain is charting, mobile documentation, and a certified EHR clinicians will use. Both are quote-only, so the partner conversation is seats or providers, which modules (EHR, billing, engagement, RCM), and how charts and claim history migrate.

How we evaluated

We scored both products on those five criteria plus a sixth: the realistic cost of switching a live schedule, a live claims file, and a live chart. Vendor claims come from current public product and certification pages. A cell we could not source is "not published."

Pricing is absent on both sides. Do not quote a forum range. Ask each vendor for a quote that names how they count a provider versus a staff user, which modules are in, whether clearinghouse and payment processing sit outside the subscription, how C-CDA or claims history export if you leave, and who owns the first 30 days of denial work after go-live.

Certified EHR status is a criterion, not a slogan. According to ONC, 91% of U.S. office-based physicians had adopted a certified EHR as of 2024, with 95% using any EHR. A practice still choosing between Kareo and Drchrono is usually an independent group in the remaining gap, or a group replacing a certified system that clinicians hate. According to ONC, 79.9% of solo physicians used a certified EHR in 2024 versus 98.5% in groups of 51-plus, which is why this comparison is written for small practices, not health systems.

Who Kareo is actually for

Kareo is for an independent practice that wants billing, scheduling, and a connected clinical record without buying a hospital EHR. The lineage is practice management and revenue cycle for small groups: eligibility, claims, denials, patient balances, and a calendar that talks to the same database as the chart.

The workflow it is built around is the front desk and the biller. A visit is scheduled. Eligibility is checked. The encounter produces a superbill. The claim goes out. Denials come back into a work queue. Patient balances collect through a portal or statement. Practices whose office manager lives in A/R, not in the note, feel this immediately.

Kareo is a weaker fit when the physicians' complaint is the note, the tablet, the specialty template, or e-prescribing speed, and billing is already outsourced to a competent shop. Replacing a clinical workflow to "fix billing" is how a practice spends six months recertifying staff and still sends the same claims.

Request a Kareo quote that states: how providers are counted, whether billing-only staff are included, which clinical and engagement modules are in the bundle, what happens to historical claims, and whether outsourced RCM is a separate line. Provider count and module mix usually drive the number.

Who Drchrono is actually for

Drchrono is for a practice that wants the chart to be the system of record: customizable notes, mobile documentation, e-prescribing including controlled substances, lab orders, and a schedule that sits on the same platform. According to Drchrono, the platform holds 32 million-plus patients and books 1.2 million-plus appointments per month. The vendor publishes ONC certification details for Drchrono EHR 11.0, including a CHPL product number and a CMS EHR Certification ID, which is the documentation a practice should ask to see against its own reporting needs.

The workflow it is built around is the encounter. The clinician documents. Orders go out. The superbill is available for billing. Reminders and a patient portal sit around the visit. Practices whose physicians still chart after hours, or who picked an iPad-first workflow years ago and still want it, are the ones who shortlist Drchrono for clinical reasons.

Drchrono is a weaker fit when the practice does not intend to chart in it and only wants a billing engine. You can buy billing on the platform, but you are still taking an EHR implementation. Practices that wanted "just claims" and received a full clinical rollout are the ones who stall.

Request a Drchrono quote that states: provider versus staff seats, which tiers include eRx, EPCS, RCM, and telehealth, how C-CDA export works, and what the first 90 days of template-building look like. Seat mix and whether you take RCM usually drive the number.

Kareo vs Drchrono at a glance

Positioning from current product pages; pricing rows reflect a confirmed absence of a public figure for both.

Published scale and certification flags

Drchrono figures from the EHR product page and the ONC certification page. Kareo does not publish a matching patient count on a current Kareo-branded page we can cite here. Public price is 0 for both because neither figure may be printed.

Office-based EHR adoption context

Percent figures from the ONC National EHR Survey for 2024, already cited above. 91% of office-based physicians used a certified EHR in 2024.

According to Drchrono, Drchrono EHR v 11.0 was certified by Drummond Group on May 31, 2022, which is the certification packet a practice should match against its own Promoting Interoperability reporting rather than taking a sales slide as proof. According to Tebra, more than 42,000 practices in the United States are growing with the current independent-practice platform that now houses the Kareo billing lineage, a scale figure for the office-and-A/R side of this comparison.

Quote questions a partner should send in writing

Counts are the practice's internal checklist, not vendor SLAs. Send the same list to both vendors.

Kareo: pros and cons

Pros: billing, eligibility, and claims sit at the center of the independent-practice workflow; staff seats are often easier to justify when the product is sold around providers rather than every login; a connected chart exists so the biller is not working from paper superbills.

Cons: quote-only pricing; clinicians who needed a specialty-first note may still fight the chart; a 2021 platform combination means demos can wander into growth and reputation tools the practice did not come to buy.

No-show work is adjacent either way. Why Patient No-Shows Persist — and How to Cut Them in 2026 is the companion read if the original complaint was empty slots rather than denials.

Drchrono: pros and cons

Pros: charting, mobile documentation, e-prescribing, and labs are the product, not an add-on; published ONC certification details you can hand to a compliance officer; appointment volume on the current EHR page is large enough to be a real installed base.

Cons: quote-only pricing; buying it "just for billing" still drags in an EHR implementation; template-building is a real month of clinician time that demos skip.

If part of the clinical load is behavioral health or virtual visits, Cut 3 Telehealth Gaps Hurting Behavioral Health Groups 2026 is worth stacking next to this comparison so telehealth is not an afterthought in the quote.

What switching actually costs

The quote is not the switch. The switch is every future appointment, every open claim, every medication list, and every staff member who still opens the old login "just to check."

Moving onto Kareo means mapping patients, insurance, and claim history, reconnecting clearinghouse and payment posting, and retraining front desk plus billers. Cash flow is the risk. A practice that cuts over on a Monday without a denial owner by Friday will feel it in week three when ERA posting does not match. Ask for a dated conversion plan against your claim volume, not a generic "we migrate you."

Moving onto Drchrono means the same patient and schedule move plus clinical templates, eRx enrollment, lab interfaces, and C-CDA import. Clinicians will be slower in month one. Budget reduced visit volume or extra scribe time rather than pretending go-live is free. Ask how many specialty templates are prebuilt for your field and who builds the rest.

Authorization and payer work often sits outside both EHRs. Scale Home Health Authorization Reverification in 2026 is the check if a slice of the practice still lives on recertification calendars the new EHR will not own.

After eligibility clears, US Tech Automations can connect the day's schedule to the billing workflow so visits that completed still route to claim creation without a second spreadsheet. When denials return, US Tech Automations can monitor the denial queue and flag claims that never re-filed, which is the follow-up step most practices discover only after the first month of the new EHR.

US Tech Automations is not a third EHR. It is the automation layer some practices add when Kareo or Drchrono owns the record and the rest of the chain still leaks into inboxes.

The verdict, and who should pick the other one

If the office manager's week is eligibility, claims, and A/R, Kareo is the pick, and the memo should say the price is quote-only pending provider count and modules. If the physicians' week is notes, e-prescribing, and after-hours charting, Drchrono is the pick, with the same quote-only caveat plus a template-building plan.

Pick the other one when the pain does not match. A Kareo buy to fix a specialty note is the wrong project. A Drchrono buy to replace an outsourced biller, while clinicians refuse to chart in it, leaves you paying for an EHR you do not use. Some practices will keep billing in Kareo's lineage and chart elsewhere; that only works if someone owns the superbill handoff.

US Tech Automations belongs in that handoff, not as a substitute for either vendor. Name which product is the system of record for the chart and which is the system of record for the claim before you add anything else.

Ask both vendors, in writing, for: how they count providers, which modules are in, clearinghouse and payments, a sample data map, C-CDA or claims export, and a dated 90-day plan. If the quote is one line called "platform," send it back.

A practice that still faxes records between the chart and the biller after go-live did not finish the project. Write the handoff as a named step: visit complete, superbill created, claim submitted, ERA posted, patient balance sent. If either product cannot show that chain on a real patient from your specialty, keep shopping. The five criteria at the top of this page are not a slogan; they are the agenda for the second demo, the one you run after the first demo made both platforms look interchangeable.

FAQs

Does Kareo still exist as its own product?

Practices still search and buy on the Kareo name, and the billing engine in that lineage is what this comparison evaluates. Demos may be delivered under the current independent-practice platform brand. Ask the rep to show the billing, scheduling, and clinical screens you would actually log into.

Can Drchrono replace a billing-only workflow?

It can bill, but you are still implementing an EHR. If clinicians will not document in it, you will pay for charting tools you do not use and still need a claims process. That is a reason to keep billing where it is or to quote RCM as a separate decision.

Which one publishes a price?

Neither. Request a quote. Ask about provider versus staff seats, modules, clearinghouse, payments, and migration. Those are the drivers of the number.

How long does a switch take?

Plan on overlapping systems and a slower clinical or billing month, not a weekend cutover. Chart migrations run long when templates are custom. Claim migrations run long when ERA posting has to be re-proven. Ask for a dated plan against your visit volume.

What should we ask in the Kareo demo?

Walk eligibility, a claim, a denial, and a patient balance from the same visit. If the demo stays on a growth website, you have not evaluated billing.

What should we ask in the Drchrono demo?

Chart a real visit type, send a test eRx workflow, open a lab result, and export a C-CDA. If the demo stays on the calendar, you have not evaluated the EHR.

Key Takeaways

• Kareo is the independent-practice billing and PM pick; Drchrono is the clinical EHR pick with published certification details.

• Neither publishes a price. Quotes should name providers, modules, clearinghouse, payments, and export.

• 32 million-plus patients is Drchrono's published EHR-page count, not a Kareo figure.

• Solo certified-EHR adoption still lags large groups, which is why this choice is a small-practice problem.

• Switching cost is claims, charts, templates, and a month of slower operations.

• US Tech Automations is the handoff layer, not a third EHR.